These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 17371277)
1. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent. Raul F Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277 [TBL] [Abstract][Full Text] [Related]
2. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Meyskens FL; Gerner EW Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725 [TBL] [Abstract][Full Text] [Related]
3. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells. Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887 [TBL] [Abstract][Full Text] [Related]
4. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats. Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419 [TBL] [Abstract][Full Text] [Related]
5. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636 [TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer. Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706 [TBL] [Abstract][Full Text] [Related]
7. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO. Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299 [TBL] [Abstract][Full Text] [Related]
8. Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line. Hudson EA; Howells LM; Gallacher-Horley B; Fox LH; Gescher A; Manson MM BMC Cancer; 2003 Jan; 3():2. PubMed ID: 12525265 [TBL] [Abstract][Full Text] [Related]
9. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine. Pfaller MA; Riley J; Gerarden T J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402 [TBL] [Abstract][Full Text] [Related]
10. Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants. Carbone PP; Pirsch JD; Thomas JP; Douglas JA; Verma AK; Larson PO; Snow S; Tutsch KD; Pauk D Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):657-61. PubMed ID: 11401916 [TBL] [Abstract][Full Text] [Related]
11. Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target. Müller IB; Das Gupta R; Lüersen K; Wrenger C; Walter RD Mol Biochem Parasitol; 2008 Jul; 160(1):1-7. PubMed ID: 18455248 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Takigawa M; Verma AK; Simsiman RC; Boutwell RK Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752 [TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639 [TBL] [Abstract][Full Text] [Related]
14. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. Endo Y; Matsushima K; Onozaki K; Oppenheim JJ J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724 [TBL] [Abstract][Full Text] [Related]
15. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Heston WD; Fleischmann J; Tackett RE; Ratliff TL Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546 [TBL] [Abstract][Full Text] [Related]
16. Effects of suramin on polyamine metabolism in B16 murine melanoma cells. Gritli-Linde A; Björkman U; Delle U; Frostesjö L; Hultborn R; Hultén K; Johansson BR; Nannmark U; Linde A Anticancer Res; 1998; 18(2A):855-62. PubMed ID: 9615732 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the antiproliferative activity of human interferon by polyamine depletion. Kovach JS; Svingen PA Cancer Treat Rep; 1985 Jan; 69(1):97-103. PubMed ID: 3917854 [TBL] [Abstract][Full Text] [Related]
18. [The effect of chemically modified polyamine analogs on polyamine and putrescine biosynthesis in a cell-free test system from a rat hepatoma]. Fedoronchuk TV; Siatkin SP; Lulle IZh; Ianson IaIa; Lidak MIu; Berezov TT Biull Eksp Biol Med; 1993 Sep; 116(9):256-8. PubMed ID: 8117993 [TBL] [Abstract][Full Text] [Related]
19. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo. Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925 [TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells. Kucharzewska P; Welch JE; Svensson KJ; Belting M Exp Cell Res; 2010 Oct; 316(16):2683-91. PubMed ID: 20594968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]